|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 2001; 37:412-417 © 2001 by the American College of Cardiology Foundation |
a Second Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan
Manuscript received June 5, 2000; revised manuscript received August 23, 2000, accepted October 3, 2000.
Reprint requests and correspondence: Dr. Tomoaki Ohtsuka, Second Department of Internal Medicine, Ehime University School of Medicine, Shigenobu, Onsen-gun, Ehime 791-0295, Japan
mhamada{at}m.ehime-u.ac.jp
OBJECTIVES
This study was designed to evaluate the beneficial effect of beta-blockers on circulating cytokine levels in patients with dilated cardiomyopathy (DCM).
BACKGROUND
Elevated circulating levels of inflammatory cytokines have been reported in patients with DCM. However, alterations of the levels of inflammatory and anti-inflammatory cytokines in association with beta-blocker therapy are unknown.
METHODS
We studied 32 patients with idiopathic DCM who had been treated with digitalis, diuretics and angiotensin-converting enzyme inhibitors. In addition to this combination therapy, beta-blockers were started in all patients. Serum levels of interleukin (IL)-10, tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors (sTNF-R1 and R2) were measured at baseline and 12 weeks after the initiation of beta-blocker therapy. We also measured plasma levels of neurohumoral factors, as well as left ventricular (LV) size and function. Ten age-matched subjects with no cardiac disease served as the control group.
RESULTS
Baseline levels of IL-10, TNF-alpha and sTNF-R2 were significantly higher in patients with DCM than in control subjects (p < 0.05). There was a significant positive correlation between IL-10 and TNF-alpha levels (r = 0.545, p = 0.029). The TNF-alpha/IL-10 ratio correlated well with plasma epinephrine levels (r = 0.677, p = 0.025), and the level of sTNF-R2 was closely related to LV size. Serum levels of IL-10, TNF-alpha and sTNF-R2 were significantly decreased during beta-blocker therapy (p < 0.005).
CONCLUSIONS
Our findings indicate that beta-blockers have an important immunoregulatory role in modifying the dysregulated cytokine network in DCM. This effect of beta-blockers may be partly responsible for the efficacy of therapeutic drugs for heart failure.
| ||||||||||||||||||||||||
This article has been cited by other articles:
|
|
 |
|
  I. Liuba, H. Ahlmroth, L. Jonasson, A. Englund, A. Jonsson, K. Safstrom, and H. Walfridsson Source of inflammatory markers in patients with atrial fibrillation Europace, July 1, 2008; 10(7): 848 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Kertai, C. M. Westerhout, K. S. Varga, G. Acsady, and J. Gal Dihydropiridine calcium-channel blockers and perioperative mortality in aortic aneurysm surgery Br. J. Anaesth., June 12, 2008; (2008) aen173v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Poldermans, S. E. Hoeks, and H. H. Feringa Pre-Operative Risk Assessment and Risk Reduction Before Surgery J. Am. Coll. Cardiol., May 20, 2008; 51(20): 1913 - 1924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Loppnow, K. Werdan, and M. Buerke Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms Innate Immunity, April 1, 2008; 14(2): 63 - 87. [Abstract] [PDF]
|
|
|
|
 |
|
 L Dubey and Z Hesong Anti-inflammatory action of diltiazem in patients with unstable angina. Postgrad. Med. J., September 1, 2006; 82(971): 594 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S Schleithoff, A. Zittermann, G. Tenderich, H. K Berthold, P. Stehle, and R. Koerfer Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am. J. Clinical Nutrition, April 1, 2006; 83(4): 754 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Boos and G. Y.H. Lip Is atrial fibrillation an inflammatory disorder?: reply Eur. Heart J., April 1, 2006; 27(7): 886 - 886. [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Spodick Decreased Recognition of the Post-Myocardial Infarction (Dressler) Syndrome in the Postinfarct Setting: Does It Masquerade as "Idiopathic Pericarditis" Following Silent Infarcts? Chest, November 1, 2004; 126(5): 1410 - 1411. [Full Text] [PDF]
|
|
|
|
|
|
K. Bendjelid and J. Pugin Is Dressler Syndrome Dead? Chest, November 1, 2004; 126(5): 1680 - 1682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yuan, K. Shioji, Y. Kihara, H. Takenaka, Y. Onozawa, and C. Kishimoto Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H83 - H90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zoccali, F. Mallamaci, and G. Tripepi Novel Cardiovascular Risk Factors in End-Stage Renal Disease J. Am. Soc. Nephrol., January 1, 2004; 15(90010): S77 - 80. [Abstract] [Full Text]
|
|
|
|
|
|
S. Adamopoulos, J. T. Parissis, I. Paraskevaidis, D. Karatzas, E. Livanis, M. Georgiadis, G. Karavolias, D. Mitropoulos, D. Degiannis, and D. Th. Kremastinos Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy Eur. Heart J., December 2, 2003; 24(24): 2186 - 2196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Beattie, M. G. Shlipak, H. Liu, W. S. Browner, N. B. Schiller, and M. A. Whooley C-Reactive Protein and Ischemia in Users and Nonusers of {beta}-Blockers and Statins: Data From the Heart and Soul Study Circulation, January 21, 2003; 107(2): 245 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. O. Weinberg, M. Shimpo, G. W. De Keulenaer, C. MacGillivray, S.-i. Tominaga, S. D. Solomon, J.-L. Rouleau, and R. T. Lee Expression and Regulation of ST2, an Interleukin-1 Receptor Family Member, in Cardiomyocytes and Myocardial Infarction Circulation, December 3, 2002; 106(23): 2961 - 2966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jones and H. Montgomery The Gly389Arg beta-1 adrenoceptor polymorphism and cardiovascular disease: time for a rethink in the funding of genetic studies? Eur. Heart J., July 2, 2002; 23(14): 1071 - 1074. [Full Text] [PDF]
|
|
|
|
|
|
S. Adamopoulos, J. Parissis, D. Karatzas, C. Kroupis, M. Georgiadis, G. Karavolias, J. Paraskevaidis, K. Koniavitou, A. J. S. Coats, and D. T. Kremastinos Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fasligand system in patients with chronic heart failure J. Am. Coll. Cardiol., February 20, 2002; 39(4): 653 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Moller and J H Henriksen Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease Heart, January 1, 2002; 87(1): 9 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Bolger, R. Sharma, P. Aukrust, L. Gullestad, H. Aass, J. G. Fjeld, L. Wikeby, A. K. Andreassen, H. Ihlen, S. Simonsen, et al. Increase in Anti-Inflammatory Cytokine Levels in Chronic Heart Failure: A Measure of Treatment Success or Failure? Response Circulation, October 30, 2001; 104 (18): e97 - e97. [Full Text] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
